PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
95.27
Positive P/E while Healthcare median is negative at -2.88. Peter Lynch would investigate competitive advantages in a distressed Healthcare.
480.44
P/S exceeding 1.5x Healthcare median of 15.01. Jim Chanos would check for potential multiple compression risks.
6.70
P/B exceeding 1.5x Healthcare median of 3.55. Jim Chanos would check for potential asset write-down risks.
-52.00
Negative FCF while Healthcare median P/FCF is -10.97. Seth Klarman would investigate cash flow improvement potential.
31211.22
Positive operating cash flow while Healthcare median is negative. Peter Lynch would examine operational advantage.
6.70
Fair value ratio exceeding 1.5x Healthcare median of 3.56. Jim Chanos would check for valuation bubble risks.
0.26%
Positive earnings while Healthcare median shows losses. Peter Lynch would examine earnings quality advantage.
-1.92%
Negative FCF while Healthcare median yield is -0.33%. Seth Klarman would investigate cash flow improvement potential.